[1]
Aglawe, S. et al. 2026. Development and Evaluation of Surface-Functionalized Rifampicin Nanoparticles for Targeted Pulmonary Drug Delivery in Tuberculosis Therapy . International Journal of Aquatic Research and Environmental Studies. 6, S5 (Jul. 2026), 593–602. DOI:https://doi.org/10.70102/agcv2026.